Comparison of best supportive care, CHOP, or R-CHOP for treatment of diffuse large B-cell lymphoma in Malawi: a cost-effectiveness analysis

BACKGROUND: Cost-effectiveness data for cancer treatment are needed from sub-Saharan Africa, where diffuse large B-cell lymphoma (DLBCL) is a common, curable cancer. In high-income countries, the standard of care for DLBCL is R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednis...

Descripción completa

Detalles Bibliográficos
Autores principales: Painschab, Matthew S, Kohler, Racquel, Kimani, Stephen, Mhango, Wilberforce, Kaimila, Bongani, Zuze, Takondwa, Mithi, Victor, Kasonkanji, Edwards, Mumba, Noel, Nyasosela, Richard, Wheeler, Stephanie, Gopal, Satish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403678/
https://www.ncbi.nlm.nih.gov/pubmed/34303416
http://dx.doi.org/10.1016/S2214-109X(21)00261-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403678/
https://www.ncbi.nlm.nih.gov/pubmed/34303416
http://dx.doi.org/10.1016/S2214-109X(21)00261-8

Ejemplares similares